A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma.
第一作者机构：[1]Hebei Med Univ, Tumor Hosp Hebei Prov, Hosp 4, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Liu Lihong,Wu Lili,Huang Chen,et al.A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma.[J].JOURNAL OF CLINICAL ONCOLOGY.2020,38(15):
APA：
Liu, Lihong,Wu, Lili,Huang, Chen,Zhao, Guimin,Ma, Guangyu...&Gao, Zhe.(2020).A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma..JOURNAL OF CLINICAL ONCOLOGY,38,(15)
MLA：
Liu, Lihong,et al."A retrospective observational study on the efficacy and safety of pegylated recombinant human granulocyte-colony stimulating factor and recombinant human granulocyte-colony stimulating factor in patients with lymphoma.".JOURNAL OF CLINICAL ONCOLOGY 38..15(2020)
医学